Neurology Central

iPSC therapy success in Parkinson’s monkey models

Researchers from Kyoto University (Japan) have shown that human induced pluripotent stem (iPS) cell-derived dopaminergic (DA) progenitor cells can survive and function as midbrain dopaminergic neurons in a primate model of Parkinson’s disease (PD). The first study of its kind, this new research marks a major breakthrough in bringing iPS cell-based therapies for neurodegenerative disease closer to the clinic.
To view restricted content, please:

Leave A Comment